BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28325522)

  • 1. Giant aneurysms: A gender-specific complication of Kawasaki disease?
    Dietz SM; Kuipers IM; Tacke CEA; Koole JCD; Hutten BA; Kuijpers TW
    J Cardiol; 2017 Oct; 70(4):359-365. PubMed ID: 28325522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
    JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of medium-giant coronary artery aneurysms in Kawasaki disease.
    Jiang S; Li M; Xu K; Xie Y; Liang P; Liu C; Su Q; Li B
    Pediatr Res; 2024 Jan; 95(1):267-274. PubMed ID: 37670043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
    Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
    Matsuoka R; Furuno K; Nanishi E; Onoyama S; Nagata H; Yamamura K; Sugitani Y; Kuraoka A; Mizuno Y; Sagawa K; Honjo S; Hara T; Ohga S
    J Pediatr; 2020 Dec; 227():224-230.e3. PubMed ID: 32810506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
    Dionne A; Burns JC; Dahdah N; Tremoulet AH; Gauvreau K; de Ferranti SD; Baker AL; Son MB; Gould P; Fournier A; Newburger JW; Friedman KG
    Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31048414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients.
    Dietz SM; Kuipers IM; Koole JCD; Breur JMPJ; Fejzic Z; Frerich S; Dalinghaus M; Roest AAW; Hutten BA; Kuijpers TW
    Pediatr Cardiol; 2017 Apr; 38(4):833-839. PubMed ID: 28236162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease].
    Liu WQ; Xia B; Fan W; Yu Z; Lin WL; Chen L; Wang C; Liu BN; Li J; Yang J
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):588-593. PubMed ID: 35658368
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.
    Miyata K; Bainto EV; Sun X; Jain S; Dummer KB; Burns JC; Tremoulet AH
    Arch Dis Child; 2023 Oct; 108(10):833-838. PubMed ID: 37258054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
    Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children.
    Garrido-García LM; Morán-Villaseñor E; Yamazaki-Nakashimada MA; Cravioto P; Galván F
    Cardiol Young; 2018 Mar; 28(3):386-390. PubMed ID: 28847341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
    Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
    Liu J; Su D; Yuan P; Ye B; Qin S; Pang Y
    Cardiology; 2023; 148(5):457-468. PubMed ID: 37231847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease in infants less than one year of age.
    Rosenfeld EA; Corydon KE; Shulman ST
    J Pediatr; 1995 Apr; 126(4):524-9. PubMed ID: 7699529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.